← Leaderboards
Mark Joseph Walker
University Of California, San Diego
$999,858
Attributed
$1,999,716
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $705.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,999,716 · 1
By mechanism
R01$1,999,716 · 1
Top collaborators
- Victor Nizet3 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Victor Nizet$31,303,620
- Partho Ghosh$14,796,209
- Nan Hao$9,174,066
- Lev S Tsimring$8,030,038
- Seema S Aceves$8,899,686
Others in their field
Other Rising Stars on “Acute”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Christopher J. Lindsell · Vanderbilt University Medical Center$8,536,327
- Michael E. Roth · Public Health Institute$8,201,777
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
Research focus
Acute3-DimensionalAdjuvant StudyAdultAdjuvantAnimal EfficacyAnimal ModelAntigensAutoimmuneBrain TissueCarbohydratesAluminum SulfateCessation Of LifeChildCollaborationsCommunitiesConjugate VaccinesCross ReactivityData ModelingDisease ModelEfficacy StudyEmulsionsExperimental GroupFormulation
Grant awards (3)
Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate Models$635,274
R01 · FY2025 · AI
Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate Models$658,644
R01 · FY2024 · AI
Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate Models$705,798
R01 · FY2023 · AI